Pre-earnings brief
Reports
Tue, Oct 20, 2026
Est. EPS
$1.53
Est. revenue
$289M
Implied move
±4.5%
EPS beat rate
63%
Balchem Corporation (BCPC) operates in the specialty chemicals sector, focusing on providing innovative solutions for various industries, including food, pharmaceuticals, and agriculture. With a market cap of $5 billion, the company plays a crucial role in the materials sector, particularly as demand for specialty chemicals continues to grow.
Last quarter
In Q2-2026, Balchem reported an EPS of $1.49, exceeding expectations by 6.81%. The stock reacted positively, gaining 2.97% the following day.
EPS beat streak
1Q
EPS beat rate
63%
Avg EPS surprise
+2.40%
Avg 1-day reaction
+0.06%
Analysts expect Balchem to report solid earnings, with a consensus EPS of $1.53 and revenue of $289 million. The market is watching closely for any surprises.
Bull case
If Balchem beats expectations, it could signal strong demand and operational efficiency, potentially leading to a positive stock reaction.
Bear case
Conversely, if the company misses its targets, it may raise concerns about market conditions or internal challenges, leading to a negative stock response.
Key metrics to watch
EPS
$1.53Earnings per share is a key indicator of profitability and helps investors gauge the company's financial health.
Revenue
$289MRevenue figures provide insight into the company's sales performance and market demand for its products.
The print will turn on these.
Q1
Will the EPS exceed the consensus estimate of $1.53?
A beat on EPS would reinforce positive momentum and investor confidence in Balchem's growth prospects.
Q2
What will be the revenue figure compared to the consensus of $289 million?
Revenue performance is critical for assessing market demand and the company's ability to capitalize on growth opportunities.
—
Est. EPS
$0.24
Est. Rev
$5.7B
Impl. Move
±13.0%
Why consensus could be wrong
The Street may underestimate Balchem's ability to leverage recent market trends in specialty chemicals, which could lead to stronger-than-expected revenue growth.
Supporting evidence
Balchem has a history of exceeding EPS estimates, with a 75% beat rate over the last eight quarters.
The options market is pricing in a larger move than historical averages, suggesting that traders expect significant volatility.
Recent performance indicates that the company has been able to navigate market challenges effectively.
Key risk
If the revenue comes in significantly above $289 million, it could challenge the current cautious outlook.
Pre-commit to what would confirm each case.
The upcoming earnings report is crucial as it will provide insights into Balchem's financial health and market positioning.
Bull confirmed if
An EPS of $1.55 or higher would confirm strong operational performance and investor confidence.
Bear confirmed if
An EPS below $1.50 would raise concerns about profitability and market conditions.
What the market is pricing for the move.
Implied Move
±4.47%
Historical Avg
±2.9%
The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.
Options are pricing ±4.5% while BCPC has averaged ±2.9% over the last 8 prints — setup is pricing rich.
ATM IV
0.3%
30d HV
16.0%
Smart-money positioning from the most recent 13F filings.
Institutional
93.79%
of float
Insider
0.49%
of float
Holders
560
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
4,964,479 sh · $826.1M
15.57%
2.5%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Balchem beats expectations, history suggests a potential stock increase of around 2.93%, confirming positive market sentiment.
In line / cautious
If results are in line with expectations, the stock may experience muted movement as investors await further guidance.
Miss
A miss could lead to a decline, with history indicating an average drop of about 0.73% when expectations are not met.
House and Senate STOCK Act disclosures over the trailing 6 months.
Trades
1
1 buy·0 sells
Members
1
House only
Est. Notional
$1,001.00–$15,000.00
disclosed dollar ranges
Most Active Members
1 trade
The lines on the call that would change the story.
Vanguard Portfolio Management LLC
2,221,267 sh · $369.6M
6.97%
1.3%
Vanguard Capital Management LLC
1,445,369 sh · $240.5M
4.53%
0.9%
State Street Corporation
1,281,552 sh · $213.3M
4.02%
3.3%
Geode Capital Management, LLC
1,122,146 sh · $186.7M
3.52%
7.2%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.
Net buying
Recent Transactions
Traded Jul 10, 2026 · disclosed Sep 4, 2026
$1,001.00–$15,000.00
Filed 30–45+ days after the trade. Treat as positional context, not a leading indicator. Amounts are SEC-mandated dollar ranges, not exact values.